Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes
- PMID: 9507390
- PMCID: PMC1051214
- DOI: 10.1136/jmg.35.2.116
Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes
Abstract
Germline mutations in highly penetrant autosomal dominant genes explain about 5% of all breast cancer, and heritable mutations in the BRCA1 breast and ovarian cancer susceptibility gene account for 2-3% of breast cancer in the general population. Nevertheless, the presence of such mutations is highly predictive of disease development. Since screening for mutations is still technically laborious, we investigated whether the prior probability of being a carrier of a dominant breast cancer susceptibility gene in the youngest affected family member could be used to identify families in which the probability of finding a mutation is sufficiently high. Sixty German families with three or more cases of breast/ovarian cancer with at least two cases diagnosed under the age of 60 were screened for mutations by SSCP/CSGE and subsequent direct sequencing. Thirteen germline truncating/splicing mutations in BRCA1 were found in 33% (6/18) of the breast-ovarian cancer families and in 17% (7/42) of breast cancer only families. All the families showing mutations in BRCA1 had carrier probabilities of 0.65 or higher. In families with prior carrier probabilities above 0.6, the proportion detected was 0.46 in breast-ovarian cancer families and 0.26 in breast cancer only families. The average age at diagnosis of breast or ovarian cancer in families with BRCA1 mutations was 41.9 years and significantly lower than in families without mutations (p < 0.05). Mutation carriers and obligate carriers were also found to have cancers at other sites. The probability of being a susceptibility gene carrier, taking into account the complete pedigree information, allows uniform characterisation of all types of families for identifying those in which mutation analysis for BRCA1/2 is warranted. However, prior probabilities calculated using this method can be reduced when the correlation between genotype and phenotype is imperfect. A larger series of families needs to be investigated in this fashion to provide better estimates of the detection rate for different ranges of carrier probabilities.
Similar articles
-
Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer.Dis Markers. 1999 Oct;15(1-3):53-65. doi: 10.1155/1999/238375. Dis Markers. 1999. PMID: 10595253 Free PMC article.
-
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.J Clin Oncol. 2001 Apr 15;19(8):2247-53. doi: 10.1200/JCO.2001.19.8.2247. J Clin Oncol. 2001. PMID: 11304778
-
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.Int J Cancer. 2002 Feb 1;97(4):472-80. doi: 10.1002/ijc.1626. Int J Cancer. 2002. PMID: 11802209
-
Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers.Breast Cancer Res. 2000;2(4):283-90. doi: 10.1186/bcr70. Epub 2000 May 25. Breast Cancer Res. 2000. PMID: 11250722 Free PMC article. Review.
-
[Hereditary breast and ovarian cancer].Pathologe. 2017 May;38(3):149-155. doi: 10.1007/s00292-017-0298-5. Pathologe. 2017. PMID: 28500412 Review. German.
Cited by
-
The pathology of familial breast cancer: Clinical and genetic counselling implications of breast cancer pathology.Breast Cancer Res. 1999;1(1):48-51. doi: 10.1186/bcr13. Epub 1999 Oct 27. Breast Cancer Res. 1999. PMID: 11250683 Free PMC article. Review.
-
Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.Breast Cancer Res. 2005;7(1):R93-100. doi: 10.1186/bcr953. Epub 2004 Nov 19. Breast Cancer Res. 2005. PMID: 15642173 Free PMC article.
-
Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families.Breast Cancer Res. 2005;7(4):R465-9. doi: 10.1186/bcr1025. Epub 2005 Apr 21. Breast Cancer Res. 2005. PMID: 15987451 Free PMC article.
-
Why should primary care physicians know about breast cancer genetics?West J Med. 2001 Sep;175(3):168-73. doi: 10.1136/ewjm.175.3.168. West J Med. 2001. PMID: 11527843 Free PMC article. Review. No abstract available.
-
Computer support for genetic advice in primary care.Br J Gen Pract. 1999 Jul;49(444):572-5. Br J Gen Pract. 1999. PMID: 10621995 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous